Treatment Registry

Company

Freya

Freya publishes compounded semaglutide and compounded tirzepatide, from $150 to $249 a month.

  • 2 programs
  • 2 molecules
  • 2 readings

Read from freyameds.com on September 2, 2026. This page records what the company publishes. It is not a review and takes no position on the company.

Go to Freya

Visit Freya

We earn nothing from this link. Freya has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

What it costs

Compounded semaglutideInjection, vial$150

first month, including the required fees on record · Starting monthly price

Compounded tirzepatideInjection, vial$249

first month, including the required fees on record · Starting monthly price

Terms

StatesAll states except Alabama, Mississippi, and West Virginia

Not yet checked: pharmacy, membership and consultation fee.

Terms can differ between this company’s programs; each entry carries its own.

Programs

EntryProviderFormPer month
at its shortest term
Link
TR-0243FreyaInjection, vial$150
Starting monthly price
Record
TR-0244FreyaInjection, vial$249
Starting monthly price
Record

Notes

Recorded against this company rather than one program.

September 2, 2026

  1. 1. Site is otherwise clean and consistent — pricing on the homepage FAQ matches the treatment cards exactly, and site branding reads 'Freya' (domain freyameds.com), matching the candidate list's 'Freya Meds'.

Before you act

Cite this

Treatment Registry. (2026). Freya: recorded programs and prices. Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/freya-meds